Coronavirus disease 2019 in kidney transplant recipients: a systematic review and meta-analysis
Introduction: The clinical presentation and outcomes of coronavirus disease 2019 (COVID-19) in kidney transplant recipients (KTRs) have not been well studied. Methods: We performed a meta-analysis to examine the presenting features, outcomes and the effect of treatment on outcomes of KTRs with COVID...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer – Medknow Publications
2023-10-01
|
| Series: | Singapore Medical Journal |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.11622/smedj.2021171 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1823861435429552128 |
|---|---|
| author | Quan Yao Ho Rehena Sultana Tung Lin Lee Sobhana Thangaraju Terence Kee Htay Htay |
| author_facet | Quan Yao Ho Rehena Sultana Tung Lin Lee Sobhana Thangaraju Terence Kee Htay Htay |
| author_sort | Quan Yao Ho |
| collection | DOAJ |
| description | Introduction:
The clinical presentation and outcomes of coronavirus disease 2019 (COVID-19) in kidney transplant recipients (KTRs) have not been well studied.
Methods:
We performed a meta-analysis to examine the presenting features, outcomes and the effect of treatment on outcomes of KTRs with COVID-19. Database search was performed up to 5 September 2020 through PubMed, Embase, Web of Science, Scopus and CENTRAL.
Results:
Overall, 23 studies (1,373 patients) were included in the review and meta-analysis. The most common presenting symptoms included fever (74.0%, 95% confidence interval [CI] 65.3–81.1), cough (63.3%, 95% CI 56.5–69.6) and dyspnoea (47.5%, 95% CI 39.6–55.6). Pooled rates of mortality and critical illness were 21.1% (95% CI 15.3–28.4) and 27.7% (95% CI 21.5–34.8), respectively. Acute kidney injury occurred in 38.9% (95% CI 30.6–48.1) and dialysis was required in 12.4% (95% CI 8.3–18.0) of the cases.
Conclusion:
Kidney transplant recipients with COVID-19 have a similar clinical presentation as the general population, but they have higher morbidity and mortality. It is uncertain whether high-dose corticosteroid or hydroxychloroquine reduces the risks of mortality in KTRs with COVID-19. |
| format | Article |
| id | doaj-art-e9a2cecc524b4aac9fb6e9b275ca5421 |
| institution | Kabale University |
| issn | 0037-5675 2737-5935 |
| language | English |
| publishDate | 2023-10-01 |
| publisher | Wolters Kluwer – Medknow Publications |
| record_format | Article |
| series | Singapore Medical Journal |
| spelling | doaj-art-e9a2cecc524b4aac9fb6e9b275ca54212025-02-09T14:07:38ZengWolters Kluwer – Medknow PublicationsSingapore Medical Journal0037-56752737-59352023-10-01641059360210.11622/smedj.2021171Coronavirus disease 2019 in kidney transplant recipients: a systematic review and meta-analysisQuan Yao HoRehena SultanaTung Lin LeeSobhana ThangarajuTerence KeeHtay HtayIntroduction: The clinical presentation and outcomes of coronavirus disease 2019 (COVID-19) in kidney transplant recipients (KTRs) have not been well studied. Methods: We performed a meta-analysis to examine the presenting features, outcomes and the effect of treatment on outcomes of KTRs with COVID-19. Database search was performed up to 5 September 2020 through PubMed, Embase, Web of Science, Scopus and CENTRAL. Results: Overall, 23 studies (1,373 patients) were included in the review and meta-analysis. The most common presenting symptoms included fever (74.0%, 95% confidence interval [CI] 65.3–81.1), cough (63.3%, 95% CI 56.5–69.6) and dyspnoea (47.5%, 95% CI 39.6–55.6). Pooled rates of mortality and critical illness were 21.1% (95% CI 15.3–28.4) and 27.7% (95% CI 21.5–34.8), respectively. Acute kidney injury occurred in 38.9% (95% CI 30.6–48.1) and dialysis was required in 12.4% (95% CI 8.3–18.0) of the cases. Conclusion: Kidney transplant recipients with COVID-19 have a similar clinical presentation as the general population, but they have higher morbidity and mortality. It is uncertain whether high-dose corticosteroid or hydroxychloroquine reduces the risks of mortality in KTRs with COVID-19.https://journals.lww.com/10.11622/smedj.2021171coronavirus disease 2019covid-19kidney transplantationmeta-analysissystematic review |
| spellingShingle | Quan Yao Ho Rehena Sultana Tung Lin Lee Sobhana Thangaraju Terence Kee Htay Htay Coronavirus disease 2019 in kidney transplant recipients: a systematic review and meta-analysis Singapore Medical Journal coronavirus disease 2019 covid-19 kidney transplantation meta-analysis systematic review |
| title | Coronavirus disease 2019 in kidney transplant recipients: a systematic review and meta-analysis |
| title_full | Coronavirus disease 2019 in kidney transplant recipients: a systematic review and meta-analysis |
| title_fullStr | Coronavirus disease 2019 in kidney transplant recipients: a systematic review and meta-analysis |
| title_full_unstemmed | Coronavirus disease 2019 in kidney transplant recipients: a systematic review and meta-analysis |
| title_short | Coronavirus disease 2019 in kidney transplant recipients: a systematic review and meta-analysis |
| title_sort | coronavirus disease 2019 in kidney transplant recipients a systematic review and meta analysis |
| topic | coronavirus disease 2019 covid-19 kidney transplantation meta-analysis systematic review |
| url | https://journals.lww.com/10.11622/smedj.2021171 |
| work_keys_str_mv | AT quanyaoho coronavirusdisease2019inkidneytransplantrecipientsasystematicreviewandmetaanalysis AT rehenasultana coronavirusdisease2019inkidneytransplantrecipientsasystematicreviewandmetaanalysis AT tunglinlee coronavirusdisease2019inkidneytransplantrecipientsasystematicreviewandmetaanalysis AT sobhanathangaraju coronavirusdisease2019inkidneytransplantrecipientsasystematicreviewandmetaanalysis AT terencekee coronavirusdisease2019inkidneytransplantrecipientsasystematicreviewandmetaanalysis AT htayhtay coronavirusdisease2019inkidneytransplantrecipientsasystematicreviewandmetaanalysis |